{"id":"immunization-procedures","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reaction"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Immunization procedures involve the administration of vaccines or immunogenic preparations that train the adaptive immune system to generate antibodies and cellular immunity against target pathogens or disease-associated antigens. This approach enhances the body's ability to prevent infection or disease progression upon subsequent exposure to the pathogen or antigen.","oneSentence":"Immunization procedures stimulate the immune system to recognize and respond to specific pathogens or disease antigens, conferring protective immunity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:48:21.033Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Infectious disease prevention (specific indication not disclosed)"}]},"trialDetails":[{"nctId":"NCT07495631","phase":"NA","title":"Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":80},{"nctId":"NCT05642195","phase":"PHASE1, PHASE2","title":"Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-01","conditions":"Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Carcinoma, Non-Small-Cell Lung","enrollment":30},{"nctId":"NCT07495124","phase":"PHASE2","title":"IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence","status":"NOT_YET_RECRUITING","sponsor":"University of Washington","startDate":"2026-04-01","conditions":"Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma","enrollment":26},{"nctId":"NCT07248904","phase":"NA","title":"The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions","status":"RECRUITING","sponsor":"Cukurova University","startDate":"2026-01-16","conditions":"Human Papillomavirus (HPV), Papillomavirus Vaccines, Health Knowledge, Attitudes, Practice","enrollment":88},{"nctId":"NCT05985681","phase":"PHASE1","title":"Testing RG1-VLP Vaccine to Prevent HPV-related Cancers","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-02-27","conditions":"Human Papillomavirus-Related Carcinoma","enrollment":18},{"nctId":"NCT05680948","phase":"","title":"Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)","status":"COMPLETED","sponsor":"Istituto Superiore di Sanità","startDate":"2023-01-25","conditions":"HIV Infections","enrollment":179},{"nctId":"NCT07341191","phase":"PHASE2","title":"Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy","status":"NOT_YET_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2026-03-31","conditions":"Mantle Cell Lymphoma","enrollment":40},{"nctId":"NCT04367883","phase":"","title":"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection","status":"RECRUITING","sponsor":"Consorci Sanitari de Terrassa","startDate":"2020-03-01","conditions":"COVID19, Influenza Vaccination, ACE Inhibitors","enrollment":3000},{"nctId":"NCT07493161","phase":"NA","title":"Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-04-01","conditions":"Ph+ ALL","enrollment":100},{"nctId":"NCT06482905","phase":"PHASE1","title":"Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.","status":"RECRUITING","sponsor":"Tcelltech Inc.","startDate":"2024-09-04","conditions":"High-grade Glioma, WHO Grade Ⅳ Glioma","enrollment":52},{"nctId":"NCT07489989","phase":"PHASE2","title":"Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.","status":"RECRUITING","sponsor":"Daihong Liu","startDate":"2025-05-15","conditions":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)","enrollment":30},{"nctId":"NCT05003895","phase":"PHASE1","title":"GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-12-08","conditions":"Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma","enrollment":38},{"nctId":"NCT07488962","phase":"NA","title":"Building Cognitive Resilience to Vaccine Misinformation Using AI: Evidence From a Randomised Trial","status":"NOT_YET_RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2026-03","conditions":"Healthy","enrollment":1000},{"nctId":"NCT07042074","phase":"NA","title":"Use of Augmented Reality and Virtual Reality During Cognitive Behavioral Therapy for Needle Phobia","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-05-01","conditions":"Needle Phobia, Virtual Reality, Cognitive Behavior Treatment","enrollment":20},{"nctId":"NCT07488520","phase":"PHASE4","title":"Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire","status":"NOT_YET_RECRUITING","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2026-04","conditions":"Sickle Cell Disease (SCD)","enrollment":120},{"nctId":"NCT06738355","phase":"NA","title":"PREVENT Pilot HPV - Related Cancers Trial","status":"COMPLETED","sponsor":"University of Utah","startDate":"2025-05-20","conditions":"HPV Vaccination, Uptake Vaccination, Series Completion","enrollment":335},{"nctId":"NCT07485283","phase":"PHASE4","title":"Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia","status":"NOT_YET_RECRUITING","sponsor":"Tor Biering-Sørensen","startDate":"2026-03","conditions":"Cardiovascular Disease, Dementia","enrollment":162000},{"nctId":"NCT06976632","phase":"NA","title":"Effect of Helfer Skin Tap and Cold Application on Pain and Hemodynamics During Vaccination","status":"RECRUITING","sponsor":"Celal Bayar University","startDate":"2025-05-09","conditions":"Pregnant Women","enrollment":90},{"nctId":"NCT04779827","phase":"NA","title":"Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2021-05-04","conditions":"Vaccination Refusal, Covid19, Heart Diseases","enrollment":4476},{"nctId":"NCT06833957","phase":"","title":"Preparing for Maternal GBS Vaccine Trials in Africa","status":"RECRUITING","sponsor":"Barcelona Institute for Global Health","startDate":"2025-03-01","conditions":"Group B Streptococcus, Invasive Bacterial Diseases (IBD), Maternal Immunization","enrollment":18100},{"nctId":"NCT05705440","phase":"PHASE3","title":"A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2023-02-07","conditions":"Respiratory Syncytial Virus Infections","enrollment":3855},{"nctId":"NCT06256718","phase":"NA","title":"Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2023-05-24","conditions":"Human Papillomavirus Infection","enrollment":203},{"nctId":"NCT06736977","phase":"NA","title":"Effectiveness of Nurse-Led Education Programmes to Enhance Infection Prevention and Control Among Childcare Workers in Bangkok Daycare Centres, Thailand","status":"COMPLETED","sponsor":"Universiti Putra Malaysia","startDate":"2025-02-01","conditions":"Hand Hygiene Behavior, Infection Control, Infection Prevention","enrollment":180},{"nctId":"NCT06784726","phase":"PHASE2","title":"Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-09-04","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma","enrollment":27},{"nctId":"NCT06926062","phase":"NA","title":"Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial","status":"NOT_YET_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2026-06-01","conditions":"Human Papillomavirus-Related Carcinoma","enrollment":1900},{"nctId":"NCT07463781","phase":"","title":"Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2026-05","conditions":"Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL)","enrollment":100},{"nctId":"NCT02287428","phase":"PHASE1","title":"Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2014-11","conditions":"Glioblastoma","enrollment":56},{"nctId":"NCT06059391","phase":"PHASE2","title":"CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-12","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia","enrollment":216},{"nctId":"NCT07340853","phase":"PHASE1","title":"CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Thomas Martin, MD","startDate":"2026-02-28","conditions":"Multiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":30},{"nctId":"NCT06822881","phase":"PHASE1","title":"CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)","status":"RECRUITING","sponsor":"Beijing GoBroad Hospital","startDate":"2025-02-20","conditions":"Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc)","enrollment":27},{"nctId":"NCT06098690","phase":"NA","title":"Culturally Tailored HPV Psychoeducational Multimedia Intervention","status":"RECRUITING","sponsor":"University of Texas, El Paso","startDate":"2024-05-02","conditions":"Health Knowledge, Attitudes, Practice, Vaccine-Preventable Diseases, Intention","enrollment":63},{"nctId":"NCT07458659","phase":"EARLY_PHASE1","title":"Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma","status":"NOT_YET_RECRUITING","sponsor":"Chulalongkorn University","startDate":"2026-06-01","conditions":"Relapsed/Refractory Multiple Myeloma (MM)","enrollment":3},{"nctId":"NCT05736718","phase":"NA","title":"Engaging Clinical Champions to Improve HPV Vaccination","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-03-08","conditions":"Human Papilloma Virus","enrollment":47},{"nctId":"NCT07457060","phase":"PHASE4","title":"Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine","status":"RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2025-11-27","conditions":"Poliomyelitis","enrollment":480},{"nctId":"NCT07217145","phase":"NA","title":"PREVENT HPV -Related Cancers Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2025-10-09","conditions":"HPV Vaccination, Uptake Vaccination, Series Completion","enrollment":1455},{"nctId":"NCT07096245","phase":"NA","title":"Conectados: Social Networks and Social Media for Vaccine Uptake","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2025-09-10","conditions":"Vaccination","enrollment":507},{"nctId":"NCT07412743","phase":"NA","title":"Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers","status":"ENROLLING_BY_INVITATION","sponsor":"Kaiser Permanente","startDate":"2026-01-12","conditions":"School Health Services","enrollment":4000},{"nctId":"NCT07454226","phase":"NA","title":"ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Ph-Like, Acute Lymphoblastic Leukemia","enrollment":30},{"nctId":"NCT07455318","phase":"PHASE3","title":"Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2026-05-15","conditions":"Rabies (Healthy Volunteers)","enrollment":561},{"nctId":"NCT07164430","phase":"","title":"The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory","status":"COMPLETED","sponsor":"Nicola Irwin","startDate":"2025-09-22","conditions":"Respiratory Syncytial Virus (RSV) Infection, Respiratory Syncytial Virus Hospitalizations, Respiratory Syncytial Virus Immunization","enrollment":2792},{"nctId":"NCT07450703","phase":"NA","title":"The Effect of the Health Belief Model-Based Education Given to Mothers of Children Aged 9-15 on HPV Knowledge Level and Child Vaccination","status":"NOT_YET_RECRUITING","sponsor":"University of Gaziantep","startDate":"2026-04-01","conditions":"Cancer , Healthy, HPV - Anogenital Human Papilloma Virus Infection, Health Belief Model","enrollment":100},{"nctId":"NCT05565586","phase":"NA","title":"Impact of High Dietary Fiber on Microbiome and Vaccine Responses","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-08-23","conditions":"Influenza","enrollment":31},{"nctId":"NCT04335890","phase":"PHASE1","title":"IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma","status":"COMPLETED","sponsor":"Hasumi International Research Foundation","startDate":"2020-09-24","conditions":"Melanoma, Uveal Metastatic","enrollment":17},{"nctId":"NCT06750120","phase":"NA","title":"Addressing the Double Burden of Malnutrition in Guatemala","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-05","conditions":"Maternal Obesity Complicating Pregnancy, Birth,or Puerperium, Child Malnutrition","enrollment":1532},{"nctId":"NCT07430826","phase":"NA","title":"Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa","status":"NOT_YET_RECRUITING","sponsor":"University of Washington","startDate":"2026-11","conditions":"Neurodevelopment, Child Growth","enrollment":1260},{"nctId":"NCT00867464","phase":"","title":"Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-03-30","conditions":"Anal Carcinoma, Cervical Carcinoma, Human Papillomavirus Infection","enrollment":8670},{"nctId":"NCT06481241","phase":"NA","title":"Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-06-10","conditions":"Philadelphia Chromosome Negative ALL, Acute Lymphoblastic Leukemia, Adult","enrollment":77},{"nctId":"NCT06481228","phase":"NA","title":"Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-06-04","conditions":"Philadelphia Positive Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult","enrollment":82},{"nctId":"NCT06831383","phase":"NA","title":"The STOP-HPV Scale Up Study","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-03-23","conditions":"Human Papilloma Virus Vaccine","enrollment":100000},{"nctId":"NCT06336317","phase":"PHASE4","title":"Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE","status":"RECRUITING","sponsor":"Region Örebro County","startDate":"2024-04-24","conditions":"Acute Myocardial Infarction, Cardiovascular Diseases, Inflammatory Response","enrollment":90},{"nctId":"NCT05639972","phase":"PHASE1, PHASE2","title":"E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers","status":"RECRUITING","sponsor":"Christian Hinrichs","startDate":"2025-08-11","conditions":"HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy","enrollment":15},{"nctId":"NCT03434769","phase":"PHASE1","title":"AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Benjamin Tomlinson","startDate":"2018-07-09","conditions":"Non-Hodgkin Lymphoma","enrollment":31},{"nctId":"NCT07213128","phase":"NA","title":"Effect of IMT in Patients After Acute Exacerbations of COPD","status":"RECRUITING","sponsor":"KU Leuven","startDate":"2026-01-06","conditions":"Chronic Obstructive Pulmonary Diseases, COPD, Symptom Exacerbation","enrollment":358},{"nctId":"NCT05686226","phase":"PHASE2","title":"E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers","status":"RECRUITING","sponsor":"Christian Hinrichs","startDate":"2023-03-07","conditions":"Cervical Cancer, Throat Cancer, Oropharynx Cancer","enrollment":20},{"nctId":"NCT07417488","phase":"PHASE1","title":"GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas","status":"NOT_YET_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2026-02","conditions":"Colorectal Cancer, Small Bowel Adenocarcinoma","enrollment":18},{"nctId":"NCT04587167","phase":"NA","title":"HPV Vaccine Communication ECHO for Primary Care Clinics","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2021-05-01","conditions":"Human Papillomavirus Vaccines, Adolescent Health Services","enrollment":30},{"nctId":"NCT06808776","phase":"NA","title":"Stories to Prevent (StoP) HPV Cancers","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2025-11-18","conditions":"Human Papillomavirus Vaccination, Emotions","enrollment":200},{"nctId":"NCT06115772","phase":"","title":"Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-11-01","conditions":"Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma","enrollment":154},{"nctId":"NCT05991388","phase":"PHASE2, PHASE3","title":"A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"University of Birmingham","startDate":"2024-05-02","conditions":"B-cell Non Hodgkin Lymphoma","enrollment":210},{"nctId":"NCT05488522","phase":"PHASE1","title":"SBRT With Atezo/Bev for HCC","status":"RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2022-09-01","conditions":"Hepatocellular Carcinoma","enrollment":18},{"nctId":"NCT06622434","phase":"PHASE1, PHASE2","title":"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-11-08","conditions":"Newly Diagnosed Glioblastoma","enrollment":35},{"nctId":"NCT06505993","phase":"NA","title":"Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia","status":"SUSPENDED","sponsor":"Marc Kiviniemi","startDate":"2026-09","conditions":"COVID-19, Vaccine Hesitancy","enrollment":2250},{"nctId":"NCT04804072","phase":"NA","title":"INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2021-06-02","conditions":"HIV Infections, Drug Use, Opioid Use","enrollment":447},{"nctId":"NCT07420556","phase":"NA","title":"Effect of Different HPV Education Methods on Vaccination Intention in Young Women","status":"RECRUITING","sponsor":"Emel GÜÇLÜ CİHAN","startDate":"2025-12-15","conditions":"Human Papillomavirus (HPV) Infection, HPV Vaccination Acceptance/Intention","enrollment":117},{"nctId":"NCT07419646","phase":"NA","title":"EmpowerSpine Program","status":"NOT_YET_RECRUITING","sponsor":"Lawson Research Institute of St. Joseph's","startDate":"2026-06-01","conditions":"Internet Delivered Treatment, Spinal Cord Injury, Chronic Pain","enrollment":100},{"nctId":"NCT06607874","phase":"","title":"Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-09-16","conditions":"Human Papillomavirus-Related Cervical Carcinoma","enrollment":100},{"nctId":"NCT07418203","phase":"","title":"Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination","status":"COMPLETED","sponsor":"Université de Reims Champagne-Ardenne","startDate":"2024-12-01","conditions":"Human Papillomavirus","enrollment":29},{"nctId":"NCT06958471","phase":"NA","title":"The Effect of Individualized Developmental Care Education","status":"COMPLETED","sponsor":"University of Yalova","startDate":"2025-04-07","conditions":"Premature, Self Efficacy, Attachment","enrollment":54},{"nctId":"NCT07384637","phase":"NA","title":"Effects of Progressive Relaxation Exercises and Planned Training After Cesarean Section on Pain, Anxiety and Comfort","status":"COMPLETED","sponsor":"Cumhuriyet University","startDate":"2023-01-01","conditions":"Relaxation Exercises and Training After Cesarean Section","enrollment":129},{"nctId":"NCT07414524","phase":"","title":"VLA1553-403 Pregnancy Surveillance Study","status":"NOT_YET_RECRUITING","sponsor":"Valneva Austria GmbH","startDate":"2026-03-31","conditions":"Chikungunya Virus Infection","enrollment":200},{"nctId":"NCT07414719","phase":"NA","title":"Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2025-12-16","conditions":"Middle School and High School Students","enrollment":1422},{"nctId":"NCT04512716","phase":"EARLY_PHASE1","title":"Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-02-02","conditions":"B-ALL, DLBCL, B ALL","enrollment":12},{"nctId":"NCT06342908","phase":"PHASE1","title":"A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-06-14","conditions":"Diffuse Hemispheric Glioma, H3 G34-Mutant","enrollment":6},{"nctId":"NCT05590351","phase":"NA","title":"Efficacy of Mobile Health Application in Promotion of Exclusive Breast Feeding and Young Child Feeding Practices in Pakistan","status":"RECRUITING","sponsor":"Aga Khan University","startDate":"2026-02-02","conditions":"Malnutrition, Infant, Malnutrition, Child","enrollment":300},{"nctId":"NCT05520736","phase":"NA","title":"Mhealth Supported Bundle to Improve Vaccination Completion","status":"COMPLETED","sponsor":"Indiana University","startDate":"2022-11-01","conditions":"Vaccination","enrollment":2855},{"nctId":"NCT07052305","phase":"PHASE1","title":"NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-02-10","conditions":"Large B-cell Lymphoma","enrollment":24},{"nctId":"NCT07254702","phase":"","title":"Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil","status":"ENROLLING_BY_INVITATION","sponsor":"Valneva Austria GmbH","startDate":"2026-02-02","conditions":"Chikungunya Virus Infection","enrollment":5000},{"nctId":"NCT07163845","phase":"","title":"Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valneva Austria GmbH","startDate":"2025-09-22","conditions":"Chikungunya Virus Infection","enrollment":5354},{"nctId":"NCT07347002","phase":"","title":"Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil","status":"ENROLLING_BY_INVITATION","sponsor":"Valneva Austria GmbH","startDate":"2026-02-02","conditions":"Chikungunya Virus Infection","enrollment":1200},{"nctId":"NCT07399288","phase":"","title":"Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk","status":"COMPLETED","sponsor":"China Medical University Hospital","startDate":"2015-10-01","conditions":"Herpes Zoster, Dementia, Postherpetic Neuralgia (PHN)","enrollment":68786},{"nctId":"NCT04658680","phase":"PHASE4","title":"Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bandim Health Project","startDate":"2021-02-25","conditions":"Infant Mortality, BCG","enrollment":22800},{"nctId":"NCT07400848","phase":"","title":"Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome","status":"RECRUITING","sponsor":"University of Bern","startDate":"2026-02-15","conditions":"Post-Acute COVID-19 Vaccination Syndrome, Postviral Fatigue","enrollment":200},{"nctId":"NCT05232851","phase":"PHASE1, PHASE2","title":"A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-06-16","conditions":"Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally Advanced Oropharyngeal Carcinoma","enrollment":20},{"nctId":"NCT07388004","phase":"NA","title":"Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches","status":"RECRUITING","sponsor":"Philipps University Marburg","startDate":"2025-10-13","conditions":"Major Depressive Disorder (MDD)","enrollment":150},{"nctId":"NCT05217615","phase":"NA","title":"Parent Training for Parents of Toddlers Born Very Premature:","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2022-08-03","conditions":"Parenting, Problem Behavior, Premature Birth","enrollment":490},{"nctId":"NCT06565455","phase":"NA","title":"Growing Healthy Children and Families in Rural Arkansas","status":"RECRUITING","sponsor":"University of Arkansas","startDate":"2026-02-02","conditions":"Pediatric Obesity, Health Behavior, Risky","enrollment":64},{"nctId":"NCT07381088","phase":"NA","title":"Effect of Primary Care Education on Parents' Health-Related Perceptions and Attitudes","status":"NOT_YET_RECRUITING","sponsor":"Yuzuncu Yil University","startDate":"2026-02","conditions":"Vaccine Hesitancy, Health Education, Digital Health Literacy","enrollment":140},{"nctId":"NCT05800405","phase":"EARLY_PHASE1","title":"Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-07-20","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma","enrollment":9},{"nctId":"NCT07387211","phase":"NA","title":"Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region","status":"COMPLETED","sponsor":"The Institute of Molecular and Translational Medicine, Czech Republic","startDate":"2022-01-18","conditions":"SARS-CoV-2, SARS-CoV-2 (COVID-19) Infection","enrollment":2484},{"nctId":"NCT06728085","phase":"NA","title":"A Pragmatic Trial on Actions For Collaborative Community Engaged Strategies for HPV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-02-15","conditions":"HPV","enrollment":1838},{"nctId":"NCT03909737","phase":"PHASE4","title":"Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2020-09-24","conditions":"Stillbirths and Infant Mortality","enrollment":99700},{"nctId":"NCT07354893","phase":"","title":"Evaluation of the Effectiveness of an Educational Intervention in Splenectomized Patients","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-01-13","conditions":"Splenectomized Patients, Splenectomy, Splenectomy; Status","enrollment":100},{"nctId":"NCT06891755","phase":"NA","title":"Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3","status":"RECRUITING","sponsor":"Apreo Health, Inc.","startDate":"2025-07-15","conditions":"COPD, Emphysema","enrollment":250},{"nctId":"NCT06435351","phase":"EARLY_PHASE1","title":"Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2024-06-12","conditions":"Breast Cancer, Triple Negative Breast Cancer","enrollment":16},{"nctId":"NCT03979014","phase":"PHASE3","title":"Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-11-01","conditions":"Neoplasia","enrollment":1099},{"nctId":"NCT07374029","phase":"PHASE1","title":"Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML","status":"NOT_YET_RECRUITING","sponsor":"David Avigan","startDate":"2026-07","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse","enrollment":30},{"nctId":"NCT06010108","phase":"NA","title":"Actions For Collaborative Community Engaged Strategies for HPV","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2024-01-15","conditions":"HPV, Stigma","enrollment":350},{"nctId":"NCT07373301","phase":"PHASE2","title":"Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia","status":"NOT_YET_RECRUITING","sponsor":"Malaria Vaccine and Drug Development Center","startDate":"2026-01-19","conditions":"Plasmodium Vivax Malaria, Plasmodium Vivax Infection, Malaria Prevention","enrollment":72},{"nctId":"NCT05262920","phase":"NA","title":"Promoting Self-Management of Breast and Nipple Pain With Technology (PROMPT) for Breastfeeding Women Study","status":"COMPLETED","sponsor":"University of Connecticut","startDate":"2022-03-16","conditions":"Breastfeeding, Exclusive, Pain, Acute, Maternal Distress","enrollment":250},{"nctId":"NCT06834373","phase":"PHASE2","title":"Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-04-02","conditions":"Large B-Cell Lymphoma With IRF4 Rearrangement, Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma, Recurrent ALK-Positive Large B-Cell Lymphoma","enrollment":41}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":274,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"immunization procedures","genericName":"immunization procedures","companyName":"Changchun Zhuoyi Biological Co., Ltd","companyId":"changchun-zhuoyi-biological-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Immunization procedures stimulate the immune system to recognize and respond to specific pathogens or disease antigens, conferring protective immunity. Used for Infectious disease prevention (specific indication not disclosed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}